(Q44150443)
Statements
Galantamine provides broad benefits in patients with 'advanced moderate' Alzheimer's disease (MMSE < or = 12) for up to six months (English)
Wilkinson DG
Hock C
Farlow M
van Baelen B
1 September 2002
scientific article published in September 2002